+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Meningitis Test"

From
From
2022-2026 Global Meningitis Diagnostic Testing Market: US, Europe, Japan - Product Thumbnail Image

2022-2026 Global Meningitis Diagnostic Testing Market: US, Europe, Japan

  • Report
  • April 2022
  • Japan, United States, ... Japan, United States, Europe, Global
From
2022-2026 Global Meningitis Testing in 90 Countries - Product Thumbnail Image

2022-2026 Global Meningitis Testing in 90 Countries

  • Report
  • December 2021
  • Global
From
From
  • 14 Results (Page 1 of 1)
Loading Indicator

The Meningitis Test market is a subset of the larger Infectious Disease Testing market. It is used to detect the presence of meningitis, an inflammation of the membranes that cover the brain and spinal cord. Tests are typically conducted using a sample of cerebrospinal fluid (CSF) taken from a lumbar puncture. The test can detect the presence of bacteria, viruses, or fungi that cause meningitis. Meningitis tests are used to diagnose the condition, as well as to monitor the effectiveness of treatment. They are also used to differentiate between viral and bacterial meningitis, as well as to identify the specific type of bacteria or virus causing the infection. Companies in the Meningitis Test market include Abbott, Becton Dickinson, bioMérieux, Cepheid, DiaSorin, Hologic, and Roche. Show Less Read more